The effect of motion correction on pharmacokinetic parameter estimation in dynamic-contrast-enhanced MRI

A Melbourne1, J Hipwell, M Modat

  • 1Centre for Medical Image Computing, University College London, Gower Street, London WC1E 6BT, UK. a.melbourne@cs.ucl.ac.uk

Insights

Patient motion in dynamic-contrast-enhanced MRI (DCE-MRI) can affect pharmacokinetic analysis. This study shows that registration strategy, motion magnitude, and timing significantly influence DCE-MRI model-fitting results.

Area of Science:

  • Medical Imaging
  • Radiology
  • Biophysics

Background:

  • Dynamic-contrast-enhanced MRI (DCE-MRI) requires image registration to correct for patient motion before pharmacokinetic analysis.
  • Non-rigid registration is used, but careful strategy selection is needed to avoid misregistration artifacts, especially with enhancing features.

Purpose of the Study:

  • To investigate the impact of different image registration strategies on pharmacokinetic model-fitting results in DCE-MR mammography.
  • To analyze the influence of motion magnitude and timing on parameter estimation.

Main Methods:

  • Evaluated 52 DCE-MR mammography cases from 14 patients.
  • Compared various registration strategies, including a DCE-MRI-specific algorithm.
  • Assessed parameter changes under controlled deformations to study motion effects.

Main Results:

  • A DCE-MRI-specific registration algorithm was preferred in 50% of cases.
  • Increased motion magnitude correlated with higher model-fit residuals and affected enhancing features.
  • Motion occurring near contrast arrival had a disproportionate impact on parameter discrepancies.

Conclusions:

  • Registration algorithm choice, motion magnitude, and timing critically influence DCE-MRI pharmacokinetic parameter estimation.
  • Even small motion magnitudes can significantly alter results, underscoring the need for optimized registration techniques.

Related Concept Videos

Pharmacodynamic Models: Linear Concentration–Effect Model01:15

Pharmacodynamic Models: Linear Concentration–Effect Model

The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing drug...
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model01:14

Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model

The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A higher...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...